Clinical and Experimental Pediatrics

Search

Page Path

HOME
Search

Original Article

Effect of angiotensin II inhibition on the epithelial to mesenchymal transition in developing rat kidney

Hyung Eun Yim, Kee Hwan Yoo, In Sun Bae, Young Sook Hong, Joo Won Lee

Clin Exp Pediatr. 2009;52(8):944-952. Published online August 15, 2009

Purpose:To investigate the effects of angiotensin II inhibition on the epithelial to mesenchymal transition (EMT) in the developing kidney, we tested the expression of EMT markers and nestin in angiotensin converting enzyme (ACE) inhibitor-treated kidneys. Methods:Newborn rat pups were treated with enalapril (30 mg/kg/d) or a vehicle for 7 days. Immunohistochemistry for the expression of α-smooth muscle actin (SMA), E-cadherin, vimentin, and nestin were...

MOST CITED AHEAD-OF PRINT

Cited By 19	Neurodevelopmental outcomes of preterm infants
Cited By 18	Long COVID in children and adolescents: prevalence, clinical manifestations, and management strategies
Cited By 15	Association of gut microbiota with obesity in children and adolescents
Cited By 14	Gut microbiota affects brain development and behavior
Cited By 14	Nonalcoholic fatty liver disease and insulin resistance in children

+more

Telemedicine in pediatrics: things to consider

Lifelong impact of elevated blood pressure from childhood to adulthood

C3 glomerulopathy in children: experience at a resourcelimited center

Cerebral organoid research for pediatric patients with neurological disorders

Advancements and challenges in neonatal resuscitation: embracing laryngeal mask airways for improved outcomes

+more

ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES

FOR CONTRIBUTORS

ABOUT

Editorial Office: Korean Pediatric Society
#1606 Seocho World Officetel, 19 Seoun-ro, Seocho-ku, Seoul 06732, Korea
Tel: +82-2-3473-7306 Fax: +82-2-3473-7307 E-mail: office@e-cep.org

Clinical and Experimental Pediatrics is an open access journal. All articles are distributed under the terms of the Creative Commons Attribution NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/)